Journal of Medicinally Active Plants
Volume 10
Issue 4 Vol 10 Issue 4
12-23-2021

Targeting Flavone Deglycosylation Improves Formulation of
Whole Celery-Based Apigenin Rich Food

Follow this and additional works at: https://scholarworks.umass.edu/jmap
Part of the Plant Sciences Commons

Recommended Citation
Heeringa, Zach; Meenakshi Sudhakaran; Alison M. Gjidoda; and Andrea I. Doseff. 2021. "Targeting Flavone
Deglycosylation Improves Formulation of Whole Celery-Based Apigenin Rich Food." Journal of Medicinally
Active Plants 10, (4):74-81.
DOI: https://doi.org/10.7275/metd-3819
https://scholarworks.umass.edu/jmap/vol10/iss4/3

This Research Note is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been
accepted for inclusion in Journal of Medicinally Active Plants by an authorized editor of ScholarWorks@UMass
Amherst. For more information, please contact scholarworks@library.umass.edu.

Heeringa et al.: Targeting Flavone Deglycosylation Improves Formulation of Whole C

Targeting Flavone Deglycosylation Improves Formulation of Whole Celery-Based
Apigenin Rich Food
Zach Heeringa2,3, Y, Meenakshi Sudhakaran1,2, Y, Alison M. Gjidoda2,3, and Andrea I. Doseff2,3*
1

Molecular, Cellular and Integrative Physiology Graduate Program, Michigan State University
Department of Physiology, Michigan State University
3
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
Y
Equal first authors
2

*Corresponding author: Andrea I. Doseff; Email: doseffan@msu.edu
Manuscript received: October 26, 2021
Keywords: dietary flavonoids, drug bioavailability, breast cancer, chronic inflammation, obesity
formulation. We show that decreasing the
concentration of phosphoric acid during acid
hydrolysis aided the lowered use of potassium
hydroxide needed for neutralization. These
studies resulted in lessened saltiness while
acquiring adequate levels of apigenin aglycone.
Together, these findings would contribute to the
implementation of targeted designed whole foods
to deliver bioactive concentrations of apigenin
and similar flavonoids and thus expanding the
opportunities to prevent and treat inflammatory
diseases.

ABSTRACT
Flavone apigenin is a plant bioactive
compound abundantly found in human diets.
Apigenin has antioxidant, anti-inflammatory and
anti-carcinogenic activities, thereby presenting
promising yet unexploited prospects for the
prevention
and
treatment
of
various
inflammatory diseases. Apigenin, like other
flavones, naturally occurs in plants in its glycoside
form. However, apigenin glycosides are less
absorbed
compared
to
their
aglycone
counterparts leading to diminished antiinflammatory and anti-cancer activities in in vitro
and in vivo models. Additionally, apigenin
aglycones have poor aqueous solubility.
Consequently, limited absorption and poor
solubility pose major challenges in delivering
medically effective concentrations of apigenin. To
overcome these limitations, our group developed
a targeted designed functional whole food from
celery leaves, a rich source of apigenin, named
CEBAR (CElery Based Apigenin Rich). We
demonstrated that CEBAR efficiently increased
the intake of apigenin enabled by the removal of
glycosides. Here, we describe a method that
optimized the process by reducing the saltiness
without affecting the efficiency of apigenin
deglycosylation resulting in an improved CEBAR

INTRODUCTION
Flavonoids, one of the most abundantly found
phytochemicals, are well-recognized medicinally
active compounds or nutraceuticals known for their
health-beneficial activities (Sudhakaran et al., 2019).
Flavonoids are classified into different groups,
including flavones, based on their structural and
chemical modifications (Jiang et al., 2016).
Apigenin, a flavone present at high levels in
components of the Mediterranean diet, is a bioactive
compound exerting antioxidant, anti-inflammatory
and anti-cancer activities in cellular and in vivo
models (Cardenas et al., 2016; Gao et al., 2013; Li et
al., 2018; Nicholas et al., 2007). We recently showed
that apigenin can be used as an adjuvant therapy to
74
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improving the formulation. Our findings show that
lowering the concentration of phosphoric acid
(H3PO4) during the acid hydrolysis step facilitated
the reduced use of potassium hydroxide (KOH), thus
resulting in less saltiness while reaching equal
success in the levels of apigenin aglycone obtained.
These findings will have a beneficial impact by
improving palatability, food tolerability, and
broadening the inclusion of participants in future
clinical studies using whole food flavone-rich diets.

enhance the efficacy of the chemotherapeutic drug
doxorubicin in inducing apoptosis in threedimensional cultures of triple-negative breast cancer
cells (Sudhakaran et al., 2020). Meta-analyses have
reported a significant correlation between flavone
intake and reduced breast cancer in both pre- and
post-menopausal women (Bosetti et al., 2005; Hui et
al., 2013). Hence, flavones represent an untapped
clinical arsenal for the prevention and treatment of
inflammatory diseases. However, poor aqueous
solubility of flavones presents a major obstacle to
efficiently delivering effective concentrations of
these active compounds in a clinical setup. Thus,
delivering bioactive concentrations of flavones
through functional or medical foods has gained great
attention.
In plants, apigenin, like other flavonoids, is
generally found as glycosides (Manach et al., 2004).
Studies using mammalian cell culture and in vivo
animal models revealed that flavone glycosides are
less bioavailable compared to their aglycone
counterparts (Ahn-Jarvis et al., 2019; Liu and Hu,
2002). Previously, we showed that the lack of antiinflammatory activity of apigenin-7-O-glucoside in
macrophages is due to its limited absorption
compared with its aglycone counterpart (Hostetler et
al., 2012). We also found that the reduced absorption
of apigenin-7-O-glucoside resulted in diminished
anti-cancer activity (Sudhakaran et al., 2020). In
order to increase the delivery of apigenin at bioactive
concentrations, we developed a targeted designed
whole food from celery leaves, a rich source of
apigenin, named CEBAR (CElery Based Apigenin
Rich) (Hostetler et al., 2012). We demonstrated
efficient bioactivity of the CEBAR diet, capable of
delivering up to 1 μM apigenin, as an antiinflammatory agent in vivo in a mouse model by
reducing the levels of proinflammatory cytokines
and microRNAs at specific inflammatory sites
(Arango et al., 2015; Cardenas et al., 2016; Hostetler
et al., 2012). The targeted design of CEBAR
successfully increased the intake of apigenin by
relying on the removal of glycosides (Hostetler et al.,
2012). Here, we demonstrate a process that
diminished CEBAR saltiness while maintaining the
efficiency of apigenin deglycosylation, thereby

MATERIALS AND METHODS
Deglycosylation of flavones. Apigenin-7-Oglucoside (Sigma, USA) 80 µM was treated with
0.04 U/mL almond b-glucosidase (Sigma, USA) in
0.08 M sodium acetate at varying pH and incubated
at 37°C for 60 min. Samples were then extracted
three times with diethyl ether and subsequently
pooled. To obtain apigenin aglycone from celery,
fresh celery leaves (Apium graveolens L., Apiaceae)
were juiced, lyophilized and ground to a powder as
we previously described (Hostetler et al., 2012). One
gram of celery powder was incubated at 95-100°C in
the presence of H3PO4 (Duda Energy, USA) at
varying concentrations for 90 min. After acid
hydrolysis, samples were cooled and neutralized to
the desired pH with 20% KOH (Duda Energy, USA).
The samples were then incubated with 170 mg of
ground raw almonds (Prunus dulcis Mill., Rosaceae)
at 50°C for 2 h to induce deglycosylation. Samples
were then frozen overnight and subsequently
lyophilized and ground to a fine powder with a
mortar and pestle. At this point, the celery is referred
to as the Celery Finished Product (CFP). CFP was
extracted three times with 70% methanol for 30 min,
centrifuged, and the supernatants were pooled. The
pooled extractions were subsequently dried under N2
stream and resuspended in 0.5 mL of 70% (v/v)
methanol for HPLC analyses.
Chemical analysis of flavones.
Flavone
concentration in each sample was quantified using an
Acquity UPLC BEH C18 column (2.1 × 50 mm, 1.7
μm), and the specific flavonoids were detected using
an Acquity triple quadrupole mass spectrometer
(Waters, USA) with a dwell time of 36 ms. The
analyses were done with 0.1% formic acid (solvent
75
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treatment with the enzyme β-glucosidase at pH 5
(Hostetler et al., 2012).

A) and 0.1% formic acid in acetonitrile (solvent B)
at a flow rate of 0.4 mL/min with the following
gradient: time t=0, 99% solvent A; t=0.5 min, 99%
solvent A; t=2.5 min, 50% solvent A; t=3.0 min, 0%
solvent A; t=4.0 min, 0% solvent A; t=4.01 min, 99%
solvent A; t=5.0 min, 99% solvent A. Source
parameters included: capillary voltage of 1.0 kV in
negative mode, cone 50 V, source block 130°C,
desolvation 350°C, desolvation gas 800 L/h, cone
gas 20 L/h, and collision gas 0.16 mL/min. The
concentrations of flavones were calculated against a
standard curve generated using commercially
available pure apigenin, luteolin, chrysoeriol,
apigenin-7-O-glucoside, luteolin-7-O-glucoside and
apiin (Sigma, USA). The data was analyzed and
integrated using MassLynx 4.1 software and the
chromatograms were plotted using GraphPad Prism
software. The percentage of apigenin derived from
apigenin-7-O-glucoside is calculated as the amount
of apigenin to that of apigenin-7-O-glucoside.
Apigenin derivatives account for apigenin, apiin and
apigenin-7-O-glucoside.
Statistical analyses. Graph and chromatogram
preparation and statistical analyses were performed
using GraphPad Prism software. Statistical
differences between data were measured using a oneway or two-way ANOVA and Turkey’s post-test for
multiple comparisons. Data is presented mean ±
SEM. p value greater than 0.05 is considered
statistically insignificant.

Figure 1. Conversion of celery apiin to apigenin. Apiin
present in celery leaves is subjected to acid hydrolysis to
generate apigenin-7-O-glucoside. After neutralization,
apigenin-7-O-glucoside is deglycosylated to apigenin using
ground raw almond powder containing β-glucosidase.

Intending to reduce the salt necessary to reach an
optimal pH for the deglycosylation step, we first
evaluated the optimal range of pH required for
converting apigenin-7-O-glucoside to its aglycone
counterpart,
apigenin.
For
this
purpose,
commercially available pure apigenin-7-O-glucoside
was incubated in the presence of β-glucosidase
enzyme at various pH ranging from 5 to 4. No
significant changes in the percentage of apigenin
obtained were observed at all the pH tested, as shown
by the quantitative chemical analyses performed
(Figure 2).
We next tested the possibility to use a pH lower
than 5 to deglycosylate apigenin-7-O-glucoside to
apigenin in celery extracts. In agreement with our
previous findings (Hostetler et al., 2012), apigenin7-O-glucoside found in celery leaves extracts (Figure
3C) can be deglycosylated by incubating βglucosidase found naturally in raw almond powder at

RESULTS
Deglycosylation of apigenin-7-O-glucoside in
celery extracts is limited by pH conditions. We
previously showed that celery leaves contain high
levels of apigenin glycosides occurring as apigenin7-apisoylglucoside or apiin (Hostetler et al., 2012)
(Figure 1). We demonstrated that converting flavone
glycosides to aglycones increased their absorption in
cells and in vivo in mouse models (Hostetler et al.,
2012). For the preparation of CEBAR, apiin is first
converted to apigenin-7-O-glucoside by heating the
celery leaves at acidic pH conditions in the presence
of 1.5N H3PO4 (Figure 1). The removal of glycoside
groups from apigenin-7-O-glucoside through the
process deglycosylation is then achieved by
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pH 5 for 2 h (Figure 3D). Increasing the incubation
times to 4 or 6 h had no significant effect on the
efficiency of deglycosylation at pH 5 (Figure 3E and
F).

converted to apigenin-7-O-glucoside (Figure 4A),
will facilitate the reduction of saltiness.

Figure 2. Effect of pH on deglycosylation of apigenin-7-Oglucoside using purified β-glucosidase. Pure apigenin-7-Oglucoside was deglycosylated using purified almond βglucosidase at indicated pH at 37ºC for 60 min. Extracted
apigenin and apigenin-7-O-glucoside were detected by
HPLC analyses as described in Material and Methods. All
data represent mean ± SEM, N = 3. ns indicates no statistical
significance.

In order to decrease the amount of salt needed to
adjust the pH required for the deglycosylation step,
we next evaluated the effectiveness of performing
the deglycosylation at pH 4. The chemical analyses
of apigenin flavones showed that the amount of
apigenin-7-O-glucoside converted to apigenin
decreased at pH 4 as compared to the deglycosylation
at pH 5 at incubations times of either 4 or 6 h, as
depicted in the chromatograms (Figure 3G and H).
There was a 50% decrease in the amount of apigenin
aglycone generated at pH 4 as compared to pH 5.
Overall, these results indicate that in contrast to the
ability of the pure β-glucosidase enzyme to
effectively deglycosylate apigenin-7-O-glucoside at
a broader pH range, the deglycosylation of naturally
occurring apigenin-7-O-glucoside in celery leaves
extracts is favored by more restrictive pH conditions.

Figure 3. Effect of pH on deglycosylation of celery apigenin7-O-glucoside using raw almond powder a source of βglucosidase. HPLC chromatograms of (A and B) flavone
standards, celery extracts (C) before deglycosylation, postdeglycosylation using almond β-glucosidase at (D-F) pH 5
and (G and H) pH 4 at indicated times. Peaks represent: 1.
Apigenin-7-O-glucoside and 2. Apigenin.

Reduced concentration of phosphoric acid
results in improved salt conditions. Since regulating
pH conditions proved to have less effect on
deglycosylation, we decided to evaluate next if
changes in the acid hydrolysis, wherein apiin is
77
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lowered the amounts of KOH required to neutralize
and reach the pH 5 optimal for deglycosylation.
There was almost a decrease of 50% in the amount
of KOH used for neutralization when the
concentration of H3PO4 was reduced to 0.75N.
Importantly, we found that the deglycosylation
following these new conditions generated similar
levels of apigenin aglycone (Figure 4B). These
results demonstrate that the reduction of H3PO4
concentration combined with less salt content
resulted in a favorable deglycosylation of apigenin in
CFP.

To this end, we evaluated the effect of different
concentrations of H3PO4 on the efficacy of acid
hydrolysis and subsequent deglycosylation by
evaluating first the levels of apigenin derivatives
(apiin and apigenin-7-O-glucoside and apigenin) at
two concentrations of H3PO4. We found that
decreasing the concentration of H3PO4 to 0.75N from
1.5N did not have any significant effect on the acid
hydrolysis, as indicated by the similar levels of
apigenin-7-O-glucoside
obtained
from
the
hydrolysis of apiin at both the concentrations tested
(Figure 4B). The decreased concentration of H3PO4

Figure 4. Effect of phosphoric acid concentration on acid hydrolysis and deglycosylation of flavones in celery leaf extracts. (A)
Flowchart of experimental design. Celery extracts were subjected to acid hydrolysis at the indicated phosphoric acid
concentrations and deglycosylated using almond β-glucosidase at pH 5 for 2 h. (B) Extracted apigenin derivatives were detected
by HPLC analyses. All data represent mean ± SEM, N = 3. ns indicates no statistical significance.

The delivery of flavonoids at medically effective
concentrations in vivo is critical for its efficacy.
However, flavones are associated with poor aqueous
solubility, thereby affecting efficient delivery in
vivo. Additionally, plant flavones are commonly

DISCUSSION
Bioactive compounds such as flavonoids are
gaining immense interests as nutraceuticals for the
prevention and treatment of inflammatory diseases.
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activity (Arango et al., 2015; Hostetler et al., 2012;
Sudhakaran et al., 2020; Vargo et al., 2006).
Additionally, apigenin in colorectal adenocarcinoma
cells was highly permeable as compared to apigenin7-O-glucoside as indicated by HPLC analytical
analyses (Liu and Hu, 2002). The flavone baicalin
induces apoptosis in human breast cancer cells more
effectively than its glycoside counterpart (Yu et al.,
2013). These differences in cellular absorption may
be attributed to the planar structure of apigenin
aglycone, which is conferred by the presence of a
double bond between carbon 2 and 3 on the C ring.
This planar structure contrasts with the change in the
conformation of the structure due to the addition of
the sugar in apigenin-7-O-glycoside. Underlining the
impact of the structure on bioavailability in vivo, our
previous studies showed that glycosylation
diminished intestinal absorption of apigenin into
systemic circulation in mice fed with celery-derived
apigenin rich foods (Hostetler et al., 2012). These
observations emphasize the need for designing food
formulation that improve the delivery, solubility and
bioavailability of apigenin and similar flavones to
enhance their efficacy.
Our apigenin rich celery food formulation
CEBAR relies on hydrolysis of celery apiin to
apigenin-7-O-glucoside followed by subsequent
deglycosylation
to
apigenin
to
improve
bioavailability (Hostetler et al., 2012). We
previously showed that deglycosylation enhanced
systemic circulation of apigenin in mice fed with
CEBAR (Hostetler et al., 2012). In this study, we
improved CEBAR formulations to reduce saltiness
while maintaining the levels of deglycosylated
apigenin. We initially chose to reduce the saltiness
by optimizing pH conditions for deglycosylation
using almond derived β-glucosidase. However,
deglycosylation of apigenin-7-O-glucoside in celery
leaves was found to be favored by a restricted pH
range (Figure 4). Lowering H3PO4 concentration
during acid hydrolysis of celery extract facilitated the
decreased use of KOH. This enabled reduction in
saltiness while generating adequate levels of
apigenin aglycone through deglycosylation (Figure
4B). This will help in enhancing apigenin absorption
and confer higher bioavailability.

found in plants as glycosides which have restricted
cellular absorption compared to their aglycones
counterparts. Therefore, poor solubility and
absorption of flavonoids present a major obstacle for
their biomedical applications. The use of flavonoidrich whole foods for effective delivery presents
favorable opportunities (Ahn-Jarvis et al., 2019). We
previously developed a targeted designed whole food
from celery leaves rich in flavone apigenin, named
CEBAR, which exhibited effective bioactivity as an
anti-inflammatory agent in mouse models (Arango et
al., 2015; Cardenas et al., 2016; Hostetler et al.,
2012). Here, we reveal an efficient method to
improve CEBAR formulations by reducing the
saltiness of the preparation without affecting the
efficacy of the deglycosylation of apigenin, thereby
potentially
improving
its
delivery
and
bioavailability.
Apigenin is a bioactive flavone exhibiting anticancer, anti-inflammatory and antioxidant activities
(Salehi et al., 2019; Sudhakaran et al., 2019). Its
ability to specifically target primary human cancer
cells, without affecting cells from adjacent normal
tissues, presents unique opportunities for clinical
applications (Voss et al., 2021). We recently reported
that apigenin sensitizes human breast cancer cells to
chemotherapy by inducing apoptosis, thereby
emphasizing
its
promising
role
as
a
chemotherapeutic adjuvant in a clinical set up
(Sudhakaran et al., 2020). While the reported studies
have confirmed health beneficial impacts of pure
apigenin both in vitro and in vivo, it has been shown
to have limited solubility, characteristic of
flavonoids (Hollman, 2004). In most cellular models,
the effective apigenin concentrations range between
10 to 100 μM, amounts that are hard to achieve in
vivo. Apigenin has limited bioavailability owing to
its natural existence as a glycoside in plants, such as
apiin and apigenin-7-O-glucosides (Jiang et al.,
2016). We and others have reported that flavone
glycosides are less absorbed by cells than their
aglycone counterparts. We demonstrated that
apigenin-7-O-glucoside showed less cellular
absorption compared to its aglycone counterpart
using immunofluorescence, thereby exerting
diminished anti-inflammatory and anti-cancer
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Several other studies have reported the use of
whole food enriched with flavonoids to treat cancer
in in vivo mice models. A whole food-based
approach using freeze-dried berries and berry
extracts inhibited rodent esophagus and colon cancer
by more than 50% through DNA damage and
apoptosis (Stoner et al., 2007; Wang et al., 2011).
Dietary grape powder attenuated UVB-mediated
skin carcinogenesis in SKH-1 hairless mouse model
(Singh et al., 2019). There is a limited number of
clinical studies for cancer and inflammatory diseases
using flavonoid rich whole foods. Dietary black
freeze-dried black raspberry intervention in 28
colorectal cancer patients showed beneficial anticancer activities by inducing metabolic changes (Pan
et al., 2015). A pilot study involving patients with
biopsy-confirmed oral squamous cell carcinomas
administered with oral troches containing freezedried black raspberry powder reported that the
bioactive compounds were efficiently delivered to
the affected sites and reduced the expression of antiapoptotic and anti-inflammatory markers. However,
the study reported an adverse experience in three
participants (Knobloch et al., 2016). Nonetheless,
these studies highlight the importance of targeted
whole foods to overcome the limitations of
delivering pure flavonoids and reaching effective
bioactive concentrations.
In conclusion, CEBAR offers a promising
targeted designed whole food formulation that can
deliver effective biomedical concentrations of
medicinally active apigenin. Our improved food
formulations have efficient deglycosylation of celery
apigenin while reducing the salt content. These
findings may have profound implications by
improving food tolerability and enhancing the
potential use of CEBAR as whole food flavone-rich
adjuvants to currently available standard of care.
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